Video

Determining Treatment Efficacy in the Treatment of Myasthenia Gravis

Author(s):

A. Gordon Smith, MD, FAAN

A. Gordon Smith, MD, FAAN, discusses how to assess for treatment success and why the patient perspective is so important in deciding whether to change therapies.

Related Videos
Rita Perlingeiro, PhD
Heather Medlin, MSW
Joshua Burns, PhD
Related Content
NeuroVoices: John Brandsema, MD, on Updates in Gene Therapy at MDA 2025
February 26th 2025

NeuroVoices: John Brandsema, MD, on Updates in Gene Therapy at MDA 2025

Marco Meglio
Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test
January 10th 2025

Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test

Marco Meglio
Dipal Doshi (Credit: LinkedIn)
Published: February 24th 2025 | Updated: February 25th 2025

FDA Removes Clinical Hold on Duchenne Muscular Dystrophy Agent ENTR-601-44

Isabella Ciccone, MPH
Neurology Unwrapped: 2024’s Most Intriguing Conversations
December 27th 2024

Neurology Unwrapped: 2024’s Most Intriguing Conversations

Marco Meglio
Exciting Innovations in Neurology to Come in 2025: Insights From Baptist Health
February 20th 2025

Exciting Innovations in Neurology to Come in 2025: Insights From Baptist Health

Marco Meglio
FDA Accepts NDA for Vatiquinone as Potential Treatment for Friedreich Ataxia
February 19th 2025

FDA Accepts NDA for Vatiquinone as Potential Treatment for Friedreich Ataxia

Marco Meglio
© 2025 MJH Life Sciences

All rights reserved.